GARDP announces ‘5 BY 25’ goal in response to the growing burden of antibiotic resistant infections

Today GARDP announces its ‘5 BY 25’ goal to deliver five new treatments in response to the growing global threat of antimicrobial resistance (AMR). Drug-resistant infections already cause at least 700,000 deaths globally per year.¹ GARDP’s five treatments will focus on the priority bacterial pathogens identified by the World Health Organization (WHO).

GARDP’s Chair of the Board, Professor Ramanan Laxminarayan said, “We are in a race against time to develop new antibiotics and make them accessible to the millions of people who need them. GARDP’s remarkable progress over the last three years in building strong partnerships and a talented team positions it well to meet this ambitious new goal. We need to work together with all stakeholders, including governments, academia and civil society, philanthropic organizations and the private sector, to make this goal a reality.”